ROZEX

This brand name is authorized in Austria, Brazil, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, United Kingdom, South Africa

Active ingredients

The drug ROZEX contains one active pharmaceutical ingredient (API):

1 Methronidazole UNII 140QMO216E - METRONIDAZOLE

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. Read about Methronidazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ROZEX Cream	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06BX01	Metronidazole	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BX Other chemotherapeutics
Discover more medicines within D06BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510101401166314
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 20.833-1-02-04
Country: EE	Ravimiamet	Identifier(s): 1012644, 1012655, 1046179, 1046180, 1046191, 1046203, 1046214, 1819234, 1829943
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60536
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 047317, 088909, 126503, 566040
Country: FR	Base de données publique des médicaments	Identifier(s): 60647323, 67119549, 67763113
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139633, 146681, 162359, 198608, 28405, 28406, 29236, 29238
Country: HK	Department of Health Drug Office	Identifier(s): 34300
Country: IE	Health Products Regulatory Authority	Identifier(s): 37406, 52357, 58859, 58890, 58991
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2910
Country: JP	医薬品医療機器総合機構	Identifier(s): 2699713Q1026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008622, 1008623, 1008624, 1008625, 1008626, 1068924, 1083923, 1086980, 1090231, 1091523
Country: MT	Medicines Authority	Identifier(s): MA117/00602
Country: NL	Z-Index G-Standaard	Identifier(s): 13832778
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 33480
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5950, 5951
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100106296, 100106304, 100163035, 100258103, 100346340, 100350027, 100369771, 100394533, 100423996
Country: SG	Health Sciences Authority	Identifier(s): 08453P, 11198P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/13.4.2/0771